About the Authors
- Esther Rodríguez
-
* E-mail: estherod@vhebron.net
Affiliations Servei de Pneumologia, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain, CIBER de Enfermedades Respiratorias (CIBERES). Instituto Nacional de Salud Carlos III, Madrid, Spain
- Jaume Ferrer
-
Affiliations Servei de Pneumologia, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain, CIBER de Enfermedades Respiratorias (CIBERES). Instituto Nacional de Salud Carlos III, Madrid, Spain
- Jan-Paul Zock
-
Affiliations Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain, Servei de Pneumologia, Hospital del Mar-IMIM, Barcelona, Spain, CIBER Epidemiologia y Salud Pública (CIBERESP). Instituto Nacional de Salud Carlos III, Madrid, Spain
- Ignasi Serra
-
Affiliations Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain, Servei de Pneumologia, Hospital del Mar-IMIM, Barcelona, Spain, CIBER Epidemiologia y Salud Pública (CIBERESP). Instituto Nacional de Salud Carlos III, Madrid, Spain
- Josep M. Antó
-
Affiliations Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain, Servei de Pneumologia, Hospital del Mar-IMIM, Barcelona, Spain, CIBER Epidemiologia y Salud Pública (CIBERESP). Instituto Nacional de Salud Carlos III, Madrid, Spain, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain
- Jordi de Batlle
-
Affiliations Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain, Servei de Pneumologia, Hospital del Mar-IMIM, Barcelona, Spain, CIBER Epidemiologia y Salud Pública (CIBERESP). Instituto Nacional de Salud Carlos III, Madrid, Spain, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain
- Hans Kromhout
-
Affiliation Enviromental and Occupational Health Division, Institute for Risk Assessment Sciences, Utrecht, The Netherlands
- Roel Vermeulen
-
Affiliation Enviromental and Occupational Health Division, Institute for Risk Assessment Sciences, Utrecht, The Netherlands
- David Donaire-González
-
Affiliations Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain, Servei de Pneumologia, Hospital del Mar-IMIM, Barcelona, Spain, CIBER Epidemiologia y Salud Pública (CIBERESP). Instituto Nacional de Salud Carlos III, Madrid, Spain, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain
- Marta Benet
-
Affiliations Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain, Servei de Pneumologia, Hospital del Mar-IMIM, Barcelona, Spain, CIBER Epidemiologia y Salud Pública (CIBERESP). Instituto Nacional de Salud Carlos III, Madrid, Spain, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain
- Eva Balcells
-
Affiliations CIBER de Enfermedades Respiratorias (CIBERES). Instituto Nacional de Salud Carlos III, Madrid, Spain, Servei de Pneumologia, Hospital del Mar-IMIM, Barcelona, Spain
- Eduard Monsó
-
Affiliations CIBER de Enfermedades Respiratorias (CIBERES). Instituto Nacional de Salud Carlos III, Madrid, Spain, Servei de Pneumologia, Hospital Universitari Parc Taulí, Sabadell, Spain
- Angel Gayete
-
Affiliation Servei de Radiologia, Hospital del Mar-IMIM, Barcelona, Spain
- Judith Garcia-Aymerich
-
Affiliations Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain, Servei de Pneumologia, Hospital del Mar-IMIM, Barcelona, Spain, CIBER Epidemiologia y Salud Pública (CIBERESP). Instituto Nacional de Salud Carlos III, Madrid, Spain, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain
- the PAC-COPD Study Group
-
¶Membership of the PAC-COPD Study Group is provided in the Acknowledgments
Competing Interests
Jaume Ferrer has received financial support from Almirall, Glaxo Smithkline, Novartis, Menarini, Nycomed and Boehringer Ingelheim for scientific meetings, research grants, advisory boards and scientific talks. Esther Rodríguez has received financial support from Novartis for scientific meetings and talks. This study was partly funded by Novartis Farmacèutica, Spain. There are no patents, products in development or marketed products to declare. This does not alter the authors’ adherence to all the PLoS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: ER JF JPZ JGA. Performed the experiments: ER. Analyzed the data: ER JF JPZ IS JMA JdB HK RV DDG MB EB EM AG JGA. Contributed reagents/materials/analysis tools: ER JF JPZ IS JMA JdB HK RV DDG MB EB EM AG JGA. Wrote the paper: ER.